how to maintain weight on tirzepatide Delivers Long-Term Loss — and the Numbers Prove It If you're struggling with weight and have prediabetes, a breakthrough treatment may offer lasting results. New data from the SURMOUNT-1 trial Who Is a Good Candidate
Description
How Common Is Nausea During Treatment Nausea was reported in approximately 4060% of participants receiving mid-to-high doses in the Phase 2 trial, with most episodes classified as mild to moderate and occurring early in treatment or after dose increases

As a service to the lipedema community, I am committed to providing my honest, clear, professional opinion

This is the hardest period

Liraglutide did significantly increase weight loss and lower total cholesterol

States must cover all medically necessary treatments for this age group including GLP-1s for obesity when a provider determines theyre medically necessary
